Tremeau Pharmaceuticals

One Broadway, 14th Floor
Cambridge
Massachusetts
02142
United States

Email: Info@TremeauRx.com

Show jobs for this employer

About Tremeau Pharmaceuticals

Tremeau is a new pharmaceutical company focused on providing non-opioid treatment options for rare diseases and other unique patient conditions with no approved treatments. Tremeau’s unique approach to acute and chronic pain in rare diseases is rooted in the mechanism of action, documented efficacy, and clinically differentiated profile of COX-2 selective NSAIDs.

LEADERSHIP:

Founder: Mark Corrigan

CEO: Bradford C. Sippy

CLINICAL TRIAL:

Please click here for clinical trial information.

4 articles with Tremeau Pharmaceuticals